Xiaoyan Wen Critical Care Medicine, Medicine, Center for Critical Care Nephrology P53 Mediates Acute Kidney Injury in Sepsis.

Slides:



Advertisements
Similar presentations
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
Advertisements

AKI Definitions Stuart L. Goldstein, MD Professor of Pediatrics University of Cincinnati College of Medicine Director, Center for Acute Care Nephrology.
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
A homo-dimer of annexin V protects against ischemia reperfusion injury in lung transplantation K Hashimoto, H Kim, H Oishi, M Chen, I Iskender, J Sakamoto,
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
IMPROVING OUR UNDERSTANDING OF DRUG ASSOCIATED AKI Sandra Kane-Gill, PharmD, MS, FCCM, FCCP Associate Professor of Pharmacy, Critical Care Medicine, and.
Malignant Melanoma and CDKN2A
CRISMA The role of AMP-protein kinase in the genesis of sepsis-induced acute kidney injury (AKI) Hernando Gomez Kui Jin Jacob Volpe Daniel Escobar Brian.
DOWNREGULATION OF G-PROTEIN COUPLED RECEPTOR SIGNALING IN THE PATHOGENESIS OF VIRAL MYOCARDITIS A.B. Patel, S. Maikarfi, R.L. DeBiasi Ankita Patel, M.D.
Biomarkers in the Cardiorenal Syndromes
©2013 Astute Medical, Inc. PN 0138 Rev B 2013/03/19
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Immunomodulation of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy Sasipha Tachaboon 1, Khajohn Tiranatanakul.
The Response of Tumor Cells to Stress and Chemotherapy The Role of PKC Etta Livneh Faculty of Health Sciences.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Therapeutic miRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Janaiah Kota,1 Raghu R. Chivukula,2 Kathryn A. O’Donnell,3,4 Erik A.
Indian Institute of Technology
Potential therapeutic target & predictive biomarker Oncogenic IGFBP2 Sonya Song ( 宋韦 ) Beijing Shijitan Hospital Department of Oncology The Capital Medical.
High Cut-Off Hemodialyzers Efficiently Remove Immunoglobulin Free Light Chains And Reduce Tubular Injury Induced By Plasma Of Patients With Multiple Myeloma.
Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.
Role of diuresis in AKI management
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
MITOCHONDRIAL BIOMARKERS IN ACUTE KIDNEY INJURY Rick G. Schnellmann, PhD Department of Drug Discovery and Biomedical Sciences SC Center for Therapeutic.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
John A. Kellum, MD, MCCM Professor of Critical Care Medicine, Medicine, Bioengineering and Clinical & Translational Science Vice Chair for Research Director,
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Bmi-1 in Cancer Cancer genetics 2012/04/ 전종철
Targeting of reactive oxygen species can be a potential therapeutic strategy for cancer treatment Ying-Ray Lee 1, San-Yuan Chen 2, and Hau-Ren Chen 3 1.
Regional Citrate Anticoagulation Limits Sepsis-Associated Tissue Injury Through The Decreased Release Of Microvesicles From Activated Leukocytes And Platelets.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardio-Pulmonary-Renal Interactions: A Multidisciplinary.
NIDA Center Genomics Projects Kathie Walters October 2008.
Risk prediction models of AKI DR.F.Haghverdi MD Outline AKI epidemiology and definition(brenner2016) Biomarkers Risk prediction models of AKI (post CABG,
THE PRESENT AND FUTURE Cardio-Pulmonary-Renal Interactions A Multidisciplinary Approach Faeq Husain-Syed, MD,*y Peter A. McCullough, MD, MPH,zx Horst-Walter.
Marco Fiorentino, MD Visiting Scholar
An AKI project for critically ill cancer patients
Biological activity of novel synthetic tylophorine analogs in MCF-7 breast cancer cells Przemysław Czajkowski 1, Edyta Andrulewicz 1, Anna Bielawska.
Gene Expression and Retinoblastoma “Cancer of the Eye”
Cellular Senescence What is it? What causes it? Why is it important
* * * * * * * Results Abstract Description of intervention/study
Novel Transcription Factor Inhibitor as Treatment for Epithelial Cell Cancers John Bushweller, Department of Molecular Physiology and Biological Physics,
Renal Progenitor Cell Differentiation After Kidney
Assessment and Diagnosis of Renal Dysfunction in the ICU
MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma
AKI in critically ill cancer patients:
Quercetin, Testosterone and Prostate Cancer - The Missing Link Kothandaraman Narasimhan1, Ralf Henkel1, 1Department of Medical Biosciences, University.
Cross-Talk between Human Mast Cells and Epithelial Cells by IgE-mediated Periostin Production in Eosinophilic Nasal Polyps Dong-Kyu Kim, MD, PhD Department.
p53 function and regulation in normal cells and cancer cells
Objectives Early initiation of continuous renal replacement therapy
By charles epigenetics.
Tubulointerstitial Injury Associated With Chemotherapeutic Agents
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
BIOLOGY 12 Cancer.
Transcriptional Signature of Histone Deacetylases in Breast cancer
Research at the Intersection of Biomarkers and Causal Inference
Yanchang Wang Biomedical Sciences
Nat. Rev. Nephrol. doi: /nrneph
EGFR signaling in renal fibrosis
p53 and Metabolism: The GAMT Connection
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
The Many Faces of PPARγ Cell
Volume 85, Issue 2, Pages (January 2014)
TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease
Volume 72, Issue 2, Pages (July 2007)
Volume 69, Issue 11, Pages (June 2006)
NODding off in acute kidney injury with progranulin?
Peter A. McCullough et al. JACC 2016;68:
Potential roles of biomarkers
The Role of TIPE2 Protein in Invasive Breast Carcinoma
Presentation transcript:

Xiaoyan Wen Critical Care Medicine, Medicine, Center for Critical Care Nephrology P53 Mediates Acute Kidney Injury in Sepsis

Novel biomarkers for AKI early diagnosis Sepsis associated Acute Kidney Injury is a serious complication with high mortality Identifying early markers of kidney damage has been difficult Two novel urine markers have been identified for AKI prediction – Tissue inhibitor of metalloproteinases-2 (TIMP-2) – Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) The underline mechanism is unclear – Speculated play roles in G1 cell cycle arrest

P53 induce cellular growth arrest in response to stresses p53 tumor suppressor protein is one of the potent adaptive genes in the cellular response to stress p53 was reported play critical roles in both ischemic and nephrotoxic AKI P53 can hold the cell cycle at the G1/S or G2/M regulation points, induce growth arrest or lead to apoptosis.

Hypothesis & Study methods Hypothesis: P53 play critical roles in sepsis associated AKI Strategy:  Apply p53 modulators  Measure cell cycle  Flow-up outcomes  Check associates between p53 activation and renal TIMP2, IGFBP7 expressions

P53 was modulated upon treatments

P53 modulators affect epithelial cells G0G1 and G2M growth arrest in the kidney

P53 modulators affect leukocytes G0G1 and G2M growth arrest in the kidneys

P53 modulators affect leukocyte profile

P53 activity mediates kidney dysfunction

TIMP2 was secreted in the kidneys during sepsis * Sham CLP 48 hours post CLP

P53 modulators affect TIMP2 secretion CLP CLP + UCN CLP + Pifi TIMP2DAPI

P53 modulators affect TIMP2.IGFBP7 secretion TIMP2 IGFBP7 DAPI TIMP2 IGFBP7 DAPI Sham UCN CLP Pifi

Anti-TIMP2 treatments had no effects on kidney function

Anti-IGFBP7 treatments had no effects on kidney function

Conclusion  P53 induce cell cycle arrest of both renal tubular epithelial cells and leukocytes during sepsis  P53 induced renal tubular epithelial cells’ growth arrest is one of the vital mechanisms leading to acute kidney injury in sepsis  Tubular cells secreted TIMP2 and IGFBP7 are the downstream signals of p53 activation, and could be used as one of the auxiliary diagnostic tools for acute kidney injury in sepsis patients.

Acknowledgement John A. Kellum MD Visiting fellows Jicheng Zhang, MD PhD Xiaojian Wan, MD PhD Xin Qu, MD PhD Liyan Cui, MD PhD Center for Critical Care Nephrology (CCCN) CRISMA David Emlet, PhD Jacob Volpe  Pittsburgh Institute For Neurodegenerative Diseases (PIND)  Thomas E. Starzl Transplantaion Institute (STI) Flow Core  Center for Biological Imaging (CBI), Department of Physiology and Cell Biology  Astute Medical Inc.

Questions?